Shetal Vyas

Shetal Vyas is a seasoned professional with extensive experience in the life sciences sector, currently serving as an Advisory Board Member at Aquent and an Independent Board Director at KJT. Vyas has contributed as an Angel Investor at Burnout Anticipation Technologies Inc. and held various leadership roles at Ferring Pharmaceuticals, including Vice President and General Manager of Uro-Oncology, Vice President of Operations, and Business Unit Head for Microbiome, Urology, and Gastroenterology. Additionally, Vyas has served as Vice President of Marketing at Pentec Health. Vyas is furthering professional development through Executive Education at Harvard Business School, focusing on women in corporate governance.